Cointime

PNP Therapeutics

company

About

PNP Therapeutics is engaged in the development of technology and proprietary products for the treatment of cancer.

  • 1 - 10

Highlights

Total Funding Amount
$0.92M
Funding Rounds
1
Investors
1

Details

Last Funding Type
Series B
Last Funding Money Raised
$0.92M
Industries
Biotechnology,Pharmaceutical,Therapeutics
Founded date
Jan 1, 2000
Number Of Employee
1 - 10
Operating Status
Active

PNP Therapeutics is an early-stage, biopharmaceutical company engaged in the development of a platform technology and proprietary products for the treatment of cancer. At the center of PNP's Therapeutic System is a patented enzyme (E. coli purine nucleoside phosphorylase) that has been shown to work with a variety of well-characterized nucleoside prodrugs generating active metabolites with high levels of anti-tumor activity.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$0.92M
PNP Therapeutics has raised a total of $0.92M in funding over 2 rounds. Their latest funding was raised on Jun 7, 2007 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Jun 7, 2007 Series B $0.92M 1 Greer Capital Advisors — Detail

Investors

Number of Lead Investors
Number of Investors
1
1
PNP Therapeutics is funded by 1 investors. Greer Capital Advisors are the most recent investors.
Investor Name Lead Investor Funding Round
Greer Capital Advisors Yes Series B
Cointime
เนื้อหา
บริษัท